• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Simultaneous treatment of Samter triad and prurigo nodularis with dupilumab.

作者信息

Bloomstein Joshua D, Hawkes Jason E

机构信息

Department of Dermatology, University of California Davis, Sacramento, California.

出版信息

JAAD Case Rep. 2021 Oct 15;18:20-22. doi: 10.1016/j.jdcr.2021.10.005. eCollection 2021 Dec.

DOI:10.1016/j.jdcr.2021.10.005
PMID:34778501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8577416/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a646/8577416/3d292479103b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a646/8577416/ee9af739dd3b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a646/8577416/e4e407e935d1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a646/8577416/3d292479103b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a646/8577416/ee9af739dd3b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a646/8577416/e4e407e935d1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a646/8577416/3d292479103b/gr3.jpg

相似文献

1
Simultaneous treatment of Samter triad and prurigo nodularis with dupilumab.使用度普利尤单抗同时治疗Samter三联征和结节性痒疹。
JAAD Case Rep. 2021 Oct 15;18:20-22. doi: 10.1016/j.jdcr.2021.10.005. eCollection 2021 Dec.
2
Recalcitrant prurigo nodularis treated successfully with dupilumab.度普利尤单抗成功治疗顽固性结节性痒疹。
JAAD Case Rep. 2019 May 8;5(5):471-473. doi: 10.1016/j.jdcr.2019.03.016. eCollection 2019 May.
3
Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis: our experience of efficacy.度普利尤单抗治疗特应性皮炎伴结节性痒疹样皮损：疗效观察。
J Dermatolog Treat. 2021 Jun;32(4):453-454. doi: 10.1080/09546634.2019.1659479. Epub 2019 Sep 2.
4
Dupilumab for prurigo nodularis: Case series and review of the literature.度普利尤单抗治疗结节性痒疹：病例系列及文献综述
Dermatol Ther. 2020 Mar;33(2):e13222. doi: 10.1111/dth.13222. Epub 2020 Jan 16.
5
Dupilumab Treatment for Prurigo Nodularis and Pruritis.度普利尤单抗治疗结节性痒疹和瘙痒症。
J Drugs Dermatol. 2019 Sep 1;18(9):940-942.
6
Dupilumab for the Treatment of Prurigo Nodularis.度普利尤单抗治疗结节性痒疹。
Skin Therapy Lett. 2023 Nov;28(6):7-9.
7
Delayed Hyperpigmented Injection Site Reactions Due to Chronic Dupilumab Use.长期使用度普利尤单抗导致的延迟性注射部位色素沉着反应
Cureus. 2023 Apr 11;15(4):e37441. doi: 10.7759/cureus.37441. eCollection 2023 Apr.
8
Post-Stroke Asymmetric Prurigo Nodularis Responding to Dupilumab Treatment: A Case Report.中风后不对称性结节性痒疹对度普利尤单抗治疗有反应：一例报告
Brain Sci. 2022 May 5;12(5):605. doi: 10.3390/brainsci12050605.
9
Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks.度普利尤单抗治疗结节性痒疹：长达84周的真实疗效
J Clin Med. 2024 Feb 2;13(3):878. doi: 10.3390/jcm13030878.
10
Dupilumab as promising treatment for prurigo nodularis: current evidences.度普利尤单抗治疗结节性痒疹的疗效观察：现状及进展
J Dermatolog Treat. 2022 May;33(3):1306-1311. doi: 10.1080/09546634.2021.1886232. Epub 2021 Feb 15.

引用本文的文献

1
Dupilumab in Inflammatory Skin Diseases: A Systematic Review.度普利尤单抗治疗炎症性皮肤病：系统评价。
Biomolecules. 2023 Mar 31;13(4):634. doi: 10.3390/biom13040634.
2
Dupilumab for the treatment of prurigo nodularis: A systematic review.度普利尤单抗治疗结节性痒疹的系统评价。
Front Immunol. 2023 Jan 20;14:1092685. doi: 10.3389/fimmu.2023.1092685. eCollection 2023.
3
Rapid resolution of widespread cutaneous lichen planus and generalized pruritus in an elderly patient following treatment with dupilumab.在一名老年患者接受度普利尤单抗治疗后，广泛的皮肤扁平苔藓和全身性瘙痒迅速缓解。

本文引用的文献

1
Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.美泊利珠单抗靶向阿司匹林加重性呼吸系统疾病中的多种免疫细胞。
J Allergy Clin Immunol. 2021 Aug;148(2):574-584. doi: 10.1016/j.jaci.2021.05.043. Epub 2021 Jun 16.
2
Dupilumab: A Review of Present Indications and Off-Label Uses.度普利尤单抗：当前适应证及超说明书用药综述
J Investig Allergol Clin Immunol. 2022 Apr 19;32(2):97-115. doi: 10.18176/jiaci.0682. Epub 2021 Mar 3.
3
Dupilumab as Add-on Therapy for Chronic Rhinosinusitis With Nasal Polyposis in Aspirin Exacerbated Respiratory Disease.
JAAD Case Rep. 2022 Oct 29;30:108-110. doi: 10.1016/j.jdcr.2022.10.019. eCollection 2022 Dec.
度普利尤单抗作为阿司匹林加重性呼吸系统疾病伴鼻息肉的慢性鼻-鼻窦炎的附加治疗药物。
Am J Rhinol Allergy. 2021 May;35(3):399-407. doi: 10.1177/1945892420961969. Epub 2020 Sep 23.
4
Prurigo nodularis: Pathogenesis and management.结节性痒疹：发病机制与治疗。
J Am Acad Dermatol. 2020 Dec;83(6):1567-1575. doi: 10.1016/j.jaad.2020.04.182. Epub 2020 May 24.
5
Omalizumab treatment in Samter's triad: case series and review of the literature.奥马珠单抗治疗 Samter 三联征：病例系列和文献复习。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):8124-8129. doi: 10.26355/eurrev_201909_19031.
6
Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management.阿司匹林加重性呼吸疾病：流行病学、病理生理学及管理
Med Sci (Basel). 2019 Mar 17;7(3):45. doi: 10.3390/medsci7030045.
7
Reduced Itch Associated With Dupilumab Treatment In 4 Patients With Prurigo Nodularis.度普利尤单抗治疗4例结节性痒疹患者后瘙痒减轻
JAMA Dermatol. 2019 Jan 1;155(1):121-122. doi: 10.1001/jamadermatol.2018.3906.
8
Targeting key proximal drivers of type 2 inflammation in disease.针对 2 型炎症疾病的关键近端驱动因素。
Nat Rev Drug Discov. 2016 Jan;15(1):35-50. doi: 10.1038/nrd4624. Epub 2015 Oct 16.
9
Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis.结节性痒疹表皮中活化的 STAT6 和 STAT3 的核定位。
Br J Dermatol. 2011 Nov;165(5):990-6. doi: 10.1111/j.1365-2133.2011.10498.x. Epub 2011 Sep 29.
10
Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease.慢性增生性嗜酸性鼻窦炎作为阿司匹林诱发的呼吸道疾病的预测指标
Ann Allergy Asthma Immunol. 2005 Jun;94(6):652-7. doi: 10.1016/S1081-1206(10)61323-3.